Age: 13.0
Sex: F
Vaccine: HPV4
Symptoms: Arthralgia, Chronic inflammatory demyelinating polyradiculoneuropathy, Dyspnoea, Endometriosis, Fatigue
Clinical narrative: postural orthostatic tachycardia syndrome (POTS) / migraines / joint and body pain / heart palpitations, tremors, shortness of breath; transient vision disturbance / vision problems; small fiber polyneuropathy / heart palpitations; chronic inflammatory demyelinating polyneuropathy (CIDP) / Gardasil-induced autoimmune disorder; endometriosis / fatigue; Information has been received regarding a case in litigation, from a lawyer, referring to a female patient (pt), who was currently an adult. The pt's medical history, concurrent conditions and concomitant medications were not reported.  On unknown dates, the pt was vaccinated with three doses of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) intramuscular injection (dose, route, strength, lot# and expiration date were not reported) for preventing cervical cancer, as recommended by a physician assistant and with her mother's consent..     On unknown dates since she was 13 years old, following her quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) injections, pt experienced migraines, fatigue, joint and body pain, heart palpitations, tremors, shortness of breath, and vision problems. Pt was ultimately diagnosed with postural orthostatic tachycardia syndrome (POTS), transient vision disturbance (visual impairment), small fiber polyneuropathy (small fibre neuropathy), chronic inflammatory demyelinating polyneuropathy (chronic inflammatory demyelinating polyradiculoneuropathy) (CIDP), and endometriosis. As the months progressed, so did pt's symptoms. She was seen by multiple physicians and specialists for her complaints. It was not until the summer of 2020 that pt began to suspect that quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) was the cause of her symptoms and injuries. As a result of her post-quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) symptoms, pt had been unable to engage in activities that a normal young person would enjoy. Post-quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) injections, pt's academic performance and social life were negatively impacted. Pt contended that her quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) Injections caused her to develop serious and debilitating autoimmune, autonomic, and neurological, injuries, including but not limited to POTS, transient vision disturbance, small fiver polyneuropathy, CIDP, and endometriosis, as well as a constellation of adverse symptoms, complications, injuries, and other adverse events, many of which were alleged herein and all of which were caused by quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) or otherwise linked to her quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL)-induced autoimmune disorder. As a proximate result of Company's wrongful acts and omissions and its negligent and fraudulent testing, labeling, manufacturing, marketing and promotion of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL), pt had suffered and continued to suffer severe and permanent physical injuries, and associated symptomology and had suffered severe and permanent emotional injuries, including pain and suffering. Pt also had a substantial fear of suffering additional and ongoing harms, including but not limited to now being at an increased risk of cancer, and future symptoms and harms associated with her injuries caused by quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL). As a direct and proximate result of her quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL)-induced injuries, pt had suffered and continued to suffer economic losses, including considerable financial expenses for medical care and treatment, and diminished income capacity, and she would continue to incur these losses and expenses in the future. Outcome of all the events was not recovered. The lawyer considered all the events to be related to quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL).   The lawyer considered all the events to be serious due to disability. Upon internal view, the event CIDP was determined to be medically significant.